High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q4
FY2026Q1
FY2026Q2
755.29M
+31.32%
1.599
-23.13%
770.49M
+27.64%
1.589
+12.68%
835.04M
+24.91%
1.790
-15.57%
Estimates Revision
The market is revising Upward the revenue expectations for Axon Enterprise, Inc. (AXON) for FY2025, with the revenue forecasts being adjusted by 0.9% over the past three months. During the same period, the stock price has changed by -24.41%.
Revenue Estimates for FY2025
Revise Upward
+0.9%
In Past 3 Month
EPS Estimates for FY2025
Revise Downward
-6.49%
In Past 3 Month
Stock Price
Go Down
-24.41%
In Past 3 Month
14 Analyst Rating
Wall Street analysts forecast AXON stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for AXON is 814.58 USD with a low forecast of 610.00 USD and a high forecast of 925.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
13 Buy
1 Hold
0 Sell
Strong Buy
Current: 550.610
Low
610.00
Averages
814.58
High
925.00
Current: 550.610
Low
610.00
Averages
814.58
High
925.00
RBC Capital
Outperform
initiated
$860
2025-11-17
Reason
RBC Capital
Price Target
$860
2025-11-17
initiated
Outperform
Reason
RBC Capital initiated coverage of Axon with an Outperform rating and $860 price target. The company's 25% revenue growth should sustain, driven by cross-sell/up-sell opportunities within the U.S. state and local public safety market, continued penetration into emerging customer verticals, and expansion into new product categories, the analyst tells investors in a research note. RBC believes Axon has a "strong position in a large and growing addressable market."
Goldman Sachs
Michael Ng
Buy
downgrade
$940 -> $800
2025-11-05
Reason
Goldman Sachs
Michael Ng
Price Target
$940 -> $800
2025-11-05
downgrade
Buy
Reason
Goldman Sachs analyst Michael Ng lowered the firm's price target on Axon to $800 from $940 and keeps a Buy rating on the shares. Axon missed Q3 gross profit and bookings expectations due to timing-related weakness in Software & Services, though Connected Devices performed solidly across TASER, sensors, and platforms, the analyst tells investors in a research note. Management guided to a strong Q4 rebound, reiterating high bookings growth and highlighting growing international and retail demand, including major overseas deals. Ongoing adoption of the AI Era Plan and acquisitions of Carbyne and Prepared position AXON to modernize 911 operations, though near-term financial impact remains minimal, Goldman says.
Piper Sandler
Overweight
to
NULL
downgrade
$893 -> $753
2025-11-05
Reason
Piper Sandler
Price Target
$893 -> $753
2025-11-05
downgrade
Overweight
to
NULL
Reason
Piper Sandler lowered the firm's price target on Axon to $753 from $893 and keeps an Overweight rating on the shares. The firm notes shares were down about 20% after hours given the roughly in line print most aren't used to seeing from this management team, slowdown in some of the lead metrics, and high-multiple to begin with. While the quarter itself wasn't inspiring, Piper actually thinks there's a lot to like underneath.
UBS
Neutral
downgrade
$840 -> $610
2025-11-05
Reason
UBS
Price Target
$840 -> $610
2025-11-05
downgrade
Neutral
Reason
UBS lowered the firm's price target on Axon to $610 from $840 and keeps a Neutral rating on the shares. Axon reported a "mixed" Q3, as orders disappointed but the outlook and business monument remain strong, the analyst tells investors in a research note.
Piper Sandler
initiated
$893
2025-09-23
Reason
Piper Sandler
Price Target
$893
2025-09-23
initiated
Reason
Piper Sandler initiated coverage of Axon with an Overweight rating and $893 price target.
Piper Sandler
Overweight
initiated
$893
2025-09-23
Reason
Piper Sandler
Price Target
$893
2025-09-23
initiated
Overweight
Reason
Piper Sandler initiated coverage of Axon with an Overweight rating and $893 price target. The firm cites the company's product innovation and large total addressable market for its bullish share stance. Axon operates in a "very sticky market" and is expanding in areas like artificial intelligence and drones, the analyst tells investors in a research note. Piper says Axon's product portfolio can target 2B frontline workers and its current penetration in law enforcement is low.
See All Ratings
Valuation Metrics
The current forward P/E ratio for Axon Enterprise Inc (AXON.O) is 79.68, compared to its 5-year average forward P/E of 80.31. For a more detailed relative valuation and DCF analysis to assess Axon Enterprise Inc 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
Fair
5Y Average PE
80.31
Current PE
79.68
Overvalued PE
104.66
Undervalued PE
55.97
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
N/A
5Y Average EV/EBITDA
54.60
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
69.80
Undervalued EV/EBITDA
39.39
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
N/A
5Y Average PS
11.77
Current PS
0.00
Overvalued PS
15.81
Undervalued PS
7.73
Financials
Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
FCF Margin - %
N/A
Net Margin - %
N/A
ROIC
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds areBuying! The buying amount has increased 1255.57% over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
AXON News & Events
Events Timeline
(ET)
2025-11-04
16:11:35
Axon increases FY25 revenue forecast to $2.74B, up from $2.65B-$2.73B
2025-11-04
16:09:31
Axon projects Q4 revenue between $750M and $755M, surpassing consensus estimate of $746.28M.
2025-11-04
16:08:35
Axon announces Q3 non-GAAP EPS of $1.17, falling short of consensus estimate of $1.54
Sign Up For More Events
Sign Up For More Events
News
![[object Object]](https://d5bp8bijhhba2.cloudfront.net/image/cover_image/e67fbf1cf667c313222da5c94d405acfd89713997b7c725bc6069909afd0b1d2.png)
Preview
4.5
12-01TipRanksDaily Update on QQQ ETF for December 1, 2025
![[object Object]](https://d5bp8bijhhba2.cloudfront.net/image/cover_image/0eeeb99c0725ab0b4c617e648e829293afb6da3162fc884bf9a87b624d3fbed1.png)
Preview
6.5
11-29MarketWatch16 Software Stocks for Investors Exploring Value Opportunities
![[object Object]](https://d5bp8bijhhba2.cloudfront.net/image/cover_image/4fc98689a39b294bad2371a660cdb9e9f47df458b5494ef21e445e0da8e72247.png)
Preview
4.5
11-29Barron'sNovember's Top and Bottom Performing Stocks in the S&P 500
Sign Up For More News
People Also Watch
FAQ
What is Axon Enterprise Inc (AXON) stock price today?
What is Axon Enterprise Inc (AXON)'s business?
What is the price predicton of AXON Stock?
What is Axon Enterprise Inc (AXON)'s revenue for the last quarter?
What is Axon Enterprise Inc (AXON)'s earnings per share (EPS) for the last quarter?
What changes have occurred in the market's expectations for Axon Enterprise Inc (AXON)'s fundamentals?
How many employees does Axon Enterprise Inc (AXON). have?